According to Latest Study, the global market for Human Milk Oligosaccharides (HMO) should grow from US$ 467.7 million in 2022 to US$ 1227.5 million by 2029, with a CAGR of 14.5% for the period of 2023-2029.
Global key players of human milk oligosaccharides (HMO) include Abbott, Glycom, Chr. Hansen (Jennewein), etc. The top three players hold a share about 81%. North America is the largest market, has a share about 47%, followed by Europe and Asia-Pacific, with share 33% and 19%, separately.
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
This report aims to provide a comprehensive study of the global market for Human Milk Oligosaccharides (HMO). Report Highlights:
(1) Global Human Milk Oligosaccharides (HMO) market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Human Milk Oligosaccharides (HMO) market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Human Milk Oligosaccharides (HMO) market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Human Milk Oligosaccharides (HMO) segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Human Milk Oligosaccharides (HMO) segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Human Milk Oligosaccharides (HMO), capacity, production and trends.
(7) Human Milk Oligosaccharides (HMO) industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
2'-FL & 3-FL
LNT & LNnT, etc.
Market segment by application, can be divided into
Infant Formula
Others
Market segment by players, this report covers
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem
1 Market Overview
1.1 Human Milk Oligosaccharides (HMO) Definition
1.2 Global Human Milk Oligosaccharides (HMO) Market Size and Forecast
1.2.1 By Revenue, Global Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
1.2.2 By Sales Volume, Global Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
1.2.3 Global Human Milk Oligosaccharides (HMO) Price Trend, 2018-2029
1.3 China Human Milk Oligosaccharides (HMO) Market Size and Forecast
1.3.1 By Revenue, China Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
1.3.2 By Sales Volume, China Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
1.3.3 China Human Milk Oligosaccharides (HMO) Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Human Milk Oligosaccharides (HMO) Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Human Milk Oligosaccharides (HMO) Share in Global Market, 2018-2029
1.4.3 Human Milk Oligosaccharides (HMO) Market Size: China VS Global, 2018-2029
1.5 Human Milk Oligosaccharides (HMO) Market Dynamics
1.5.1 Human Milk Oligosaccharides (HMO) Market Drivers
1.5.2 Human Milk Oligosaccharides (HMO) Market Restraints
1.5.3 Human Milk Oligosaccharides (HMO) Industry Trends
1.5.4 Human Milk Oligosaccharides (HMO) Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Company, 2018-2023
2.2 Global Human Milk Oligosaccharides (HMO) Sales Volume by Company, 2018-2023
2.3 Global Human Milk Oligosaccharides (HMO) Price by Company, 2018-2023
2.4 Global Human Milk Oligosaccharides (HMO) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Human Milk Oligosaccharides (HMO) Concentration Ratio
2.6 Global Human Milk Oligosaccharides (HMO) Mergers & Acquisitions, Expansion Plans
2.7 Global Human Milk Oligosaccharides (HMO) Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Human Milk Oligosaccharides (HMO) Revenue by Company, 2018-2023
3.2 China Human Milk Oligosaccharides (HMO) Sales Volume by Company, 2018-2023
3.3 China Human Milk Oligosaccharides (HMO) Human Milk Oligosaccharides (HMO) Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Human Milk Oligosaccharides (HMO) Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Human Milk Oligosaccharides (HMO) Domestic VS Export
3.6 China Market, Human Milk Oligosaccharides (HMO) Import & Export
3.6.1 China Market, Human Milk Oligosaccharides (HMO) Import & Export, 2018-2029
3.6.2 China Human Milk Oligosaccharides (HMO) Import & Export Trends
3.6.3 Main Sources of China Human Milk Oligosaccharides (HMO) Import
3.6.4 Export Destination of China Human Milk Oligosaccharides (HMO)
4 Human Milk Oligosaccharides (HMO) Production by Region
4.1 Global Human Milk Oligosaccharides (HMO) Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Human Milk Oligosaccharides (HMO) Manufacturers
4.3 Global Major Manufacturers, Human Milk Oligosaccharides (HMO) Capacity Expansion and Future Plans
4.4 Global Human Milk Oligosaccharides (HMO) Capacity by Region
4.5 Global Human Milk Oligosaccharides (HMO) Production by Region
4.5.1 Global Human Milk Oligosaccharides (HMO) Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Human Milk Oligosaccharides (HMO) Production by Region, 2018-2023
4.5.3 Global Human Milk Oligosaccharides (HMO) Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Human Milk Oligosaccharides (HMO) Industry Chain
5.2 Human Milk Oligosaccharides (HMO) Upstream Analysis
5.2.1 Human Milk Oligosaccharides (HMO) Core Raw Materials
5.2.2 Main Manufacturers of Human Milk Oligosaccharides (HMO) Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Human Milk Oligosaccharides (HMO) Production Mode
5.6 Human Milk Oligosaccharides (HMO) Procurement Model
5.7 Human Milk Oligosaccharides (HMO) Industry Sales Model and Sales Channels
5.7.1 Human Milk Oligosaccharides (HMO) Sales Model
5.7.2 Human Milk Oligosaccharides (HMO) Typical Distributors
6 Sights by Type
6.1 Human Milk Oligosaccharides (HMO) Classification
6.1.1 2'-FL & 3-FL
6.1.2 LNT & LNnT, etc.
6.2 By Type, Global Human Milk Oligosaccharides (HMO) Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Human Milk Oligosaccharides (HMO) Revenue, 2018-2029
6.4 By Type, Global Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029
6.5 By Type, Global Human Milk Oligosaccharides (HMO) Price, 2018-2029
7 Sights by Application
7.1 Human Milk Oligosaccharides (HMO) Segment by Application
7.1.1 Infant Formula
7.1.2 Others
7.2 By Application, Global Human Milk Oligosaccharides (HMO) Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Human Milk Oligosaccharides (HMO) Revenue, 2018-2029
7.4 By Application, Global Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029
7.5 By Application, Global Human Milk Oligosaccharides (HMO) Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Human Milk Oligosaccharides (HMO) Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Human Milk Oligosaccharides (HMO) Revenue, 2018-2029
8.3 By Region, Global Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Human Milk Oligosaccharides (HMO) Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Human Milk Oligosaccharides (HMO) Market Size Market Share
8.5 Europe
8.5.1 Europe Human Milk Oligosaccharides (HMO) Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Human Milk Oligosaccharides (HMO) Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Human Milk Oligosaccharides (HMO) Market Size Market Share
8.7 South America
8.7.1 South America Human Milk Oligosaccharides (HMO) Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Human Milk Oligosaccharides (HMO) Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Human Milk Oligosaccharides (HMO) Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Human Milk Oligosaccharides (HMO) Revenue, 2018-2029
9.3 By Country, Global Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
9.4.2 By Company, U.S. Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
9.5.2 By Company, Europe Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022
9.5.3 By Type, Europe Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
9.6.2 By Company, China Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022
9.6.3 By Type, China Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
9.7.2 By Company, Japan Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022
9.7.3 By Type, Japan Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
9.8.2 By Company, South Korea Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
9.10.2 By Company, India Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022
9.10.3 By Type, India Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Human Milk Oligosaccharides (HMO) Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Human Milk Oligosaccharides (HMO) Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Abbott
10.1.1 Abbott Company Information, Head Office, Market Area and Industry Position
10.1.2 Abbott Human Milk Oligosaccharides (HMO) Models, Specifications and Application
10.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Abbott Company Profile and Main Business
10.1.5 Abbott Recent Developments
10.2 Inbiose
10.2.1 Inbiose Company Information, Head Office, Market Area and Industry Position
10.2.2 Inbiose Human Milk Oligosaccharides (HMO) Models, Specifications and Application
10.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Inbiose Company Profile and Main Business
10.2.5 Inbiose Recent Developments
10.3 Glycom
10.3.1 Glycom Company Information, Head Office, Market Area and Industry Position
10.3.2 Glycom Human Milk Oligosaccharides (HMO) Models, Specifications and Application
10.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Glycom Company Profile and Main Business
10.3.5 Glycom Recent Developments
10.4 Chr. Hansen (Jennewein)
10.4.1 Chr. Hansen (Jennewein) Company Information, Head Office, Market Area and Industry Position
10.4.2 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Models, Specifications and Application
10.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Chr. Hansen (Jennewein) Company Profile and Main Business
10.4.5 Chr. Hansen (Jennewein) Recent Developments
10.5 Elicityl SA
10.5.1 Elicityl SA Company Information, Head Office, Market Area and Industry Position
10.5.2 Elicityl SA Human Milk Oligosaccharides (HMO) Models, Specifications and Application
10.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Elicityl SA Company Profile and Main Business
10.5.5 Elicityl SA Recent Developments
10.6 ZuChem
10.6.1 ZuChem Company Information, Head Office, Market Area and Industry Position
10.6.2 ZuChem Human Milk Oligosaccharides (HMO) Models, Specifications and Application
10.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 ZuChem Company Profile and Main Business
10.6.5 ZuChem Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Human Milk Oligosaccharides (HMO) Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Human Milk Oligosaccharides (HMO) Market Restraints
Table 3. Human Milk Oligosaccharides (HMO) Market Trends
Table 4. Human Milk Oligosaccharides (HMO) Industry Policy
Table 5. Global Human Milk Oligosaccharides (HMO) Revenue by Company, 2018-2023, US$ million
Table 6. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Company, 2018-2023
Table 7. Global Human Milk Oligosaccharides (HMO) Sales Volume by Company, 2018-2023, (Tons)
Table 8. Global Human Milk Oligosaccharides (HMO) Sales Volume Market Share by Company, 2018-2023
Table 9. Global Human Milk Oligosaccharides (HMO) Price by Company, 2018-2023, (USD/Kg)
Table 10. Global Human Milk Oligosaccharides (HMO) Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Human Milk Oligosaccharides (HMO) Mergers & Acquisitions, Expansion Plans
Table 12. Global Human Milk Oligosaccharides (HMO) Manufacturers Product Type
Table 13. China Human Milk Oligosaccharides (HMO) Revenue by Company, 2018-2023, US$ million
Table 14. China Human Milk Oligosaccharides (HMO) Revenue Market Share by Company, 2018-2023
Table 15. China Human Milk Oligosaccharides (HMO) Sales Volume by Company, 2018-2023, (Tons)
Table 16. China Human Milk Oligosaccharides (HMO) Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Human Milk Oligosaccharides (HMO) Production, Sales, Import and Export, 2018-2029, (Tons)
Table 18. China Human Milk Oligosaccharides (HMO) Import & Export Trends
Table 19. Main Sources of China Human Milk Oligosaccharides (HMO) Import
Table 20. Export Destination of China Human Milk Oligosaccharides (HMO)
Table 21. Global Headquarters and Manufacturing Base of Human Milk Oligosaccharides (HMO) Manufacturers
Table 22. Global Major Manufacturers, Human Milk Oligosaccharides (HMO) Capacity Expansion and Future Plans
Table 23. Global Human Milk Oligosaccharides (HMO) Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 24. Global Human Milk Oligosaccharides (HMO) Production by Region, 2018-2023, (Tons)
Table 25. Global Human Milk Oligosaccharides (HMO) Production Forecast by Region, 2023-2029, (Tons)
Table 26. Global Key Players of Human Milk Oligosaccharides (HMO) Upstream (Raw Materials)
Table 27. Global Human Milk Oligosaccharides (HMO) Typical Customers
Table 28. Human Milk Oligosaccharides (HMO) Typical Distributors
Table 29. By Type, Global Human Milk Oligosaccharides (HMO) Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Human Milk Oligosaccharides (HMO) Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Human Milk Oligosaccharides (HMO) Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Human Milk Oligosaccharides (HMO) Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Table 34. By Country, Global Human Milk Oligosaccharides (HMO) Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Human Milk Oligosaccharides (HMO) Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2018-2029
Table 37. By Country, Global Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Table 38. By Country, Global Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2018-2029
Table 39. Abbott Company Information, Head Office, Market Area and Industry Position
Table 40. Abbott Human Milk Oligosaccharides (HMO) Models, Specifications and Application
Table 41. Abbott Human Milk Oligosaccharides (HMO) Sales Volume (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, 2018-2023
Table 42. Abbott Company Profile and Main Business
Table 43. Abbott Recent Developments
Table 44. Inbiose Company Information, Head Office, Market Area and Industry Position
Table 45. Inbiose Human Milk Oligosaccharides (HMO) Models, Specifications and Application
Table 46. Inbiose Human Milk Oligosaccharides (HMO) Sales Volume (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, 2018-2023
Table 47. Inbiose Company Profile and Main Business
Table 48. Inbiose Recent Developments
Table 49. Glycom Company Information, Head Office, Market Area and Industry Position
Table 50. Glycom Human Milk Oligosaccharides (HMO) Models, Specifications and Application
Table 51. Glycom Human Milk Oligosaccharides (HMO) Sales Volume (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, 2018-2023
Table 52. Glycom Company Profile and Main Business
Table 53. Glycom Recent Developments
Table 54. Chr. Hansen (Jennewein) Company Information, Head Office, Market Area and Industry Position
Table 55. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Models, Specifications and Application
Table 56. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales Volume (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, 2018-2023
Table 57. Chr. Hansen (Jennewein) Company Profile and Main Business
Table 58. Chr. Hansen (Jennewein) Recent Developments
Table 59. Elicityl SA Company Information, Head Office, Market Area and Industry Position
Table 60. Elicityl SA Human Milk Oligosaccharides (HMO) Models, Specifications and Application
Table 61. Elicityl SA Human Milk Oligosaccharides (HMO) Sales Volume (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, 2018-2023
Table 62. Elicityl SA Company Profile and Main Business
Table 63. Elicityl SA Recent Developments
Table 64. ZuChem Company Information, Head Office, Market Area and Industry Position
Table 65. ZuChem Human Milk Oligosaccharides (HMO) Models, Specifications and Application
Table 66. ZuChem Human Milk Oligosaccharides (HMO) Sales Volume (Tons), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, 2018-2023
Table 67. ZuChem Company Profile and Main Business
Table 68. ZuChem Recent Developments
List of Figure
Figure 1. Human Milk Oligosaccharides (HMO) Picture
Figure 2. By Revenue, Global Human Milk Oligosaccharides (HMO) Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Human Milk Oligosaccharides (HMO) Market Size and Forecast, 2018-2029, (Tons)
Figure 4. Global Human Milk Oligosaccharides (HMO) Price Trend, 2018-2029, (USD/Kg)
Figure 5. By Revenue, China Human Milk Oligosaccharides (HMO) Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Human Milk Oligosaccharides (HMO) Market Size and Forecast, 2018-2029, (Tons)
Figure 7. China Human Milk Oligosaccharides (HMO) Price Trend, 2018-2029 (USD/Kg)
Figure 8. By Revenue, China Human Milk Oligosaccharides (HMO) Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Human Milk Oligosaccharides (HMO) Share of Global Market, 2018-2029
Figure 10. Global Human Milk Oligosaccharides (HMO) Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Human Milk Oligosaccharides (HMO) Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Human Milk Oligosaccharides (HMO) Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Human Milk Oligosaccharides (HMO) Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Human Milk Oligosaccharides (HMO) Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Human Milk Oligosaccharides (HMO) Domestic VS Export, 2022
Figure 16. Global Human Milk Oligosaccharides (HMO) Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Human Milk Oligosaccharides (HMO) Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Human Milk Oligosaccharides (HMO) Production Market Share & Forecast by Region, 2018-2029
Figure 19. Human Milk Oligosaccharides (HMO) Industry Chain
Figure 20. Human Milk Oligosaccharides (HMO) Procurement Model
Figure 21. Human Milk Oligosaccharides (HMO) Sales Model
Figure 22. Human Milk Oligosaccharides (HMO) Sales Channels, Direct Sales and Distribution
Figure 23. 2'-FL & 3-FL
Figure 24. LNT & LNnT, etc.
Figure 25. By Type, Global Human Milk Oligosaccharides (HMO) Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2018-2029
Figure 27. By Type, Global Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 28. By Type, Global Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Human Milk Oligosaccharides (HMO) Price, 2018-2029, (USD/Kg)
Figure 30. Infant Formula
Figure 31. Others
Figure 32. By Application, Global Human Milk Oligosaccharides (HMO) Revenue, 2018-2029, US$ Million
Figure 33. By Application, Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2018-2029
Figure 34. By Application, Global Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 35. By Application, Global Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2018-2029
Figure 36. By Application, Global Human Milk Oligosaccharides (HMO) Price, 2018-2029, (USD/Kg)
Figure 37. By Region, Global Human Milk Oligosaccharides (HMO) Revenue Market Share, 2018-2029
Figure 38. By Region, Global Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2018-2029
Figure 39. North America Human Milk Oligosaccharides (HMO) Revenue & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Human Milk Oligosaccharides (HMO) Revenue Market Share, 2022
Figure 41. Europe Human Milk Oligosaccharides (HMO) Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Human Milk Oligosaccharides (HMO) Revenue Market Share, 2022
Figure 43. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Human Milk Oligosaccharides (HMO) Revenue Market Share, 2022
Figure 45. South America Human Milk Oligosaccharides (HMO) Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Human Milk Oligosaccharides (HMO) Revenue Market Share, 2022
Figure 47. Middle East & Africa Human Milk Oligosaccharides (HMO) Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 49. By Company, U.S. Human Milk Oligosaccharides (HMO) Market Share, 2022
Figure 50. By Type, U.S. Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 51. By Application, U.S. Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 52. Europe Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 53. By Company, Europe Human Milk Oligosaccharides (HMO) Market Share, 2022
Figure 54. By Type, Europe Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, Europe Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 56. China Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 57. By Company, China Human Milk Oligosaccharides (HMO) Market Share, 2022
Figure 58. By Type, China Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, China Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 60. Japan Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 61. By Company, Japan Human Milk Oligosaccharides (HMO) Market Share, 2022
Figure 62. By Type, Japan Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, Japan Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 64. South Korea Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 65. By Company, South Korea Human Milk Oligosaccharides (HMO) Market Share, 2022
Figure 66. By Type, South Korea Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, South Korea Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 68. Southeast Asia Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 69. By Company, Southeast Asia Human Milk Oligosaccharides (HMO) Market Share, 2022
Figure 70. By Type, Southeast Asia Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, Southeast Asia Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 72. India Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 73. By Company, India Human Milk Oligosaccharides (HMO) Market Share, 2022
Figure 74. By Type, India Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, India Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 76. Middle East & Asia Human Milk Oligosaccharides (HMO) Sales Volume, 2018-2029, (Tons)
Figure 77. By Company, Middle East & Asia Human Milk Oligosaccharides (HMO) Market Share, 2022
Figure 78. By Type, Middle East & Asia Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, Middle East & Asia Human Milk Oligosaccharides (HMO) Sales Volume Market Share, 2022 VS 2029
Figure 80. Research Methodology
Figure 81. Breakdown of Primary Interviews
Figure 82. Bottom-up Approaches
Figure 83. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|